These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 19136943)

  • 1. Transcriptome sequencing to detect gene fusions in cancer.
    Maher CA; Kumar-Sinha C; Cao X; Kalyana-Sundaram S; Han B; Jing X; Sam L; Barrette T; Palanisamy N; Chinnaiyan AM
    Nature; 2009 Mar; 458(7234):97-101. PubMed ID: 19136943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric transcript discovery by paired-end transcriptome sequencing.
    Maher CA; Palanisamy N; Brenner JC; Cao X; Kalyana-Sundaram S; Luo S; Khrebtukova I; Barrette TR; Grasso C; Yu J; Lonigro RJ; Schroth G; Kumar-Sinha C; Chinnaiyan AM
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12353-8. PubMed ID: 19592507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
    Kim B; Lee H; Shin S; Lee ST; Choi JR
    J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
    Giacomini CP; Sun S; Varma S; Shain AH; Giacomini MM; Balagtas J; Sweeney RT; Lai E; Del Vecchio CA; Forster AD; Clarke N; Montgomery KD; Zhu S; Wong AJ; van de Rijn M; West RB; Pollack JR
    PLoS Genet; 2013 Apr; 9(4):e1003464. PubMed ID: 23637631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
    De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
    Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
    Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
    Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
    Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
    Winnes M; Lissbrant E; Damber JE; Stenman G
    Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing.
    Linhartova J; Hovorkova L; Soverini S; Benesova A; Jaruskova M; Klamova H; Zuna J; Machova Polakova K
    Mol Cancer; 2015 Apr; 14():89. PubMed ID: 25928096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention of Interstitial Genes between
    Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
    Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
    Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
    Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course.
    Byrne JL; Carter GI; Davies JM; Haynes AP; Russell NH; Cross NC
    Br J Haematol; 1998 Dec; 103(3):791-4. PubMed ID: 9858233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants.
    Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G
    BMC Cancer; 2016 Aug; 16():572. PubMed ID: 27485109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
    Cavelier L; Ameur A; Häggqvist S; Höijer I; Cahill N; Olsson-Strömberg U; Hermanson M
    BMC Cancer; 2015 Feb; 15():45. PubMed ID: 25880391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
    Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
    Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM
    Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
    Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B
    Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery.
    Piazza R; Pirola A; Spinelli R; Valletta S; Redaelli S; Magistroni V; Gambacorti-Passerini C
    Nucleic Acids Res; 2012 Sep; 40(16):e123. PubMed ID: 22570408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.